Search results
2 new COVID variants called 'FLiRT' are spreading in the U.S. What are the symptoms?
TODAY via Yahoo News· 3 days agoThe new "FLiRT" COVID-19 variants, including KP.2, are spreading in the United States. Will there be...
Study investigates cardiac cell regeneration in search of novel therapeutics
Medical Xpress· 7 hours agoWith that in mind, Mahmoud Salama Ahmed, Ph.D., and an international team of researchers have completed an investigation to uncover novel therapeutics or ...
Want To Avoid Food Poisoning? Skip These Items At Your Hotel's Breakfast Buffet
HuffPost Life via Yahoo News· 4 days agoAs for juices, both fresh and pasteurized should be cold. Since fresh juice isn’t pasteurized,...
How incentives could better treat stimulant use disorder
Medical Xpress· 6 days agoAlthough research has been underway for more than three decades to develop medications for people...
Some forms of augmented brain stimulation recommended for major depression
Medical Xpress· 1 day agoTMS was approved by the Food and Drug Administration for treatment of MDD in 2008. It uses pulsed...
...Sumitomo Pharma Announces FDA Acceptance of Supplemental New Drug Application for Vibegron in Men...
WKRN Nashville· 3 days agoSumitomo Pharma America, Inc. (SMPA), announced today the U.S. Food and Drug Administration (FDA) has accepted its ...
The 26th Annual Food Safety Summit Attracts 3,400 Food Safety Professionals In Person and Virtually,...
Morningstar· 3 days agofood safety industry professionals, researchers, policymakers, and experts from around the world participated in the 2024 Food Safety ...
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial...
Nature· 3 days agoAll procedures in the protocol were in compliance with applicable animal welfare acts and were approved by the local IACUC. The study design was based on the principles of ...
Altimmune Inc (ALT) Reports Q1 2024 Financials: A Detailed Review
GuruFocus.com via Yahoo Finance· 6 days agoThe company is preparing for an End-of-Phase 2 meeting with the U.S. Food and Drug Administration...
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
Hi-Desert Star· 2 days agoExpanded strategic relationship with Astellas with new research collaboration leveraging Poseida's proprietary allogeneic CAR-T platform to develop cell therapies targeting solid tumors